Penington Desi J, Bryant Ianthe, Riese David J
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana 47907-1333, USA.
Cell Growth Differ. 2002 Jun;13(6):247-56.
ErbB4 is a member of the epidermal growth factor receptor(EGFR) family of tyrosine kinases, which includes EGFR/ErbB1, ErbB2/HER2/Neu, and ErbB3/HER3. These receptors play important roles both in normal development and in neoplasia. For example, deregulated signaling by ErbB1 and ErbB2 is observed in many human malignancies. In contrast, the roles that ErbB4 plays in tumorigenesis and normal biological processes have not been clearly defined. To identify the biological responses that are coupled to ErbB4, we have constructed three constitutively active ErbB4 mutants. Unlike a constitutively active ErbB2 mutant, the ErbB4 mutants are not coupled to increased cell proliferation, loss of contact inhibition, or anchorage independence in a rodent fibroblast cell line. This suggests that ErbB2 and ErbB4 may play distinct roles in tumorigenesis in vivo.
ErbB4是酪氨酸激酶表皮生长因子受体(EGFR)家族的成员,该家族包括EGFR/ErbB1、ErbB2/HER2/Neu和ErbB3/HER3。这些受体在正常发育和肿瘤形成过程中均发挥重要作用。例如,在许多人类恶性肿瘤中都观察到ErbB1和ErbB2的信号传导失调。相比之下,ErbB4在肿瘤发生和正常生物学过程中所起的作用尚未明确界定。为了确定与ErbB4相关的生物学反应,我们构建了三种组成型活性ErbB4突变体。与组成型活性ErbB2突变体不同,ErbB4突变体在啮齿动物成纤维细胞系中不会导致细胞增殖增加、接触抑制丧失或锚定非依赖性。这表明ErbB2和ErbB4在体内肿瘤发生过程中可能发挥不同的作用。